Depression, Bipolar & Mood Disorders Conditions (76)
Major depressive disorder, bipolar spectrum conditions, persistent depressive disorder, and mood stabilization.
40 Master Condition Specialty Hubs
Show All 40 Hubs ×Depression, Bipolar & Mood Disorders Guides (76)
Clear All Filters ×Anabolic Steroids
What are anabolic steroids? Anabolic steroids are synthetic (man-made) versions of testosterone. Testosterone is the main sex hormone in men. It is needed to develop and maintain male sex characteristics, such as facial hair, deep voice, and muscle growth. Women do have some testosterone in their bodies, but in much smaller amounts. What are anabolic steroids used for? Health care providers use anabolic steroids to treat some hormone problems in men, delayed puberty , and muscle loss from some diseases. But some people misuse anabolic steroids by taking them in a way that's different than their provider prescribed.
Antidepressants
What are antidepressants? Antidepressants are prescription medicines to treat depression. Depression is more than feeling a little sad or "blue" for a few days. It's a very common, serious medical illness that affects your mood and general mental health . It can make you feel tired, hopeless, worried, or fearful. It can change your thinking, sleeping, and eating. Depression may make some people think about ending their lives. But antidepressants can help many people who have depression. Researchers think antidepressants may help improve the way your brain uses certain chemicals that control mood or stress.
Antisocial personality disorder
Physicians managing Antisocial personality disorder (also termed Disorder or Syndrome) (F60.2; Depression, Bipolar & Mood Disorders) utilize validated longitudinal mood in Antisocial personality disorder (F60.2: rating scales (PHQ-9) and objective PHQ-9 Symptom Severity in Antisocial personality disorder (F60.2: Score) targets (< 4 (clinical remission) (F60.2)) to prevent progression and functional morbidity.
Bipolar Disorder
What is bipolar disorder? Bipolar disorder is a mood disorder that can cause intense mood swings: Sometimes you may feel extremely "up," elated, irritable, or energized. This is called a manic episode . Other times you may feel "down," sad, indifferent, or hopeless. This is called a depressive episode . You may have both manic and depressive symptoms together. This is called a mixed episode . Along with mood swings, bipolar disorder causes changes in behavior, energy levels, and activity levels. Bipolar disorder used to be called other names, including manic depression and manic-depressive disorder.
Bipolar II disorder
Under Depression, Bipolar & Mood Disorders diagnostic criteria (F31.81), workup for Bipolar II disorder integrates sleep-wake rhythm assessment [Bipolar II disorder F31.81] with evidence-graded therapy tailored to PHQ-9 Symptom Severity in Bipolar II disorder (F31.81: Score) response.
Bipolar disorder, current episode depressed, mild or moderate severity
Recognized across U.S. clinical coding as F31.30 (Depression & Mood), Bipolar disorder, current episode depressed, mild or moderate severity is evaluated via validated longitudinal mood in Bipolar disorder, current episode depressed, mild or moderate severity (F31.30: rating scales (PHQ-9) to align day-to-day symptom relief with long-term physiological stability.
Bipolar disorder, current episode depressed, moderate
Within Depression, Bipolar & Mood Disorders practice, Bipolar disorder, current episode depressed, moderate (ICD-10 F31.32) is stratified through sleep-wake rhythm assessment [Bipolar disorder, current episode depressed, moderate F31.32], pairing targeted symptom control with longitudinal TSH & Free in Bipolar disorder, current episode depressed, moderate (F31.32: T4 Rule-Out) surveillance.
Bipolar disorder, current episode hypomanic
Clinical triage of Bipolar disorder, current episode hypomanic (F31.0) in Depression & Mood relies on structured psychiatric history [Bipolar disorder, current episode hypomanic F31.0], guiding step-wise therapeutic adjustments toward TSH & Free in Bipolar disorder, current episode hypomanic (F31.0: T4 Rule-Out) (TSH 0.8 – 2.5 mIU/L (F31.0)).
Bipolar disorder, current episode manic severe with psychotic features
For patients presenting with Bipolar disorder, current episode manic severe with psychotic features (ICD-10-CM F31.2), Depression, Bipolar & Mood Disorders protocols prioritize structured psychiatric history [Bipolar disorder, current episode manic severe with psychotic features F31.2] paired with baseline and interval Serum Vitamin D in Bipolar disorder, current episode manic severe with psychotic features (F31.2: & RBC Folate) assessment.
Bipolar disorder, current episode manic without psychotic features
Under Depression, Bipolar & Mood Disorders diagnostic criteria (F31.10), workup for Bipolar disorder, current episode manic without psychotic features integrates sleep-wake rhythm assessment [Bipolar disorder, current episode manic without psychotic features F31.10] with evidence-graded therapy tailored to PHQ-9 Symptom Severity in Bipolar disorder, current episode manic without psychotic features (F31.10: Score) response.
Bipolar disorder, current episode manic without psychotic features, mild
Recognized across U.S. clinical coding as F31.11 (Depression & Mood), Bipolar disorder, current episode manic without psychotic features, mild is evaluated via medical mimic exclusion in Bipolar disorder, current episode manic without psychotic features, mild (F31.11: (thyroid) to align day-to-day symptom relief with long-term physiological stability.
Bipolar disorder, current episode manic without psychotic features, moderate
Physicians managing Bipolar disorder, current episode manic without psychotic features, moderate (F31.12; Depression, Bipolar & Mood Disorders) utilize validated longitudinal mood in Bipolar disorder, current episode manic without psychotic features, moderate (F31.12: rating scales (PHQ-9) and objective PHQ-9 Symptom Severity in Bipolar disorder, current episode manic without psychotic features, moderate (F31.12: Score) targets (< 4 (clinical remission) (F31.12)) to prevent progression and functional morbidity.
Bipolar disorder, current episode mixed
Physicians managing Bipolar disorder, current episode mixed (F31.60; Depression, Bipolar & Mood Disorders) utilize structured psychiatric history [Bipolar disorder, current episode mixed F31.60] and objective TSH & Free in Bipolar disorder, current episode mixed (F31.60: T4 Rule-Out) targets (TSH 0.8 – 2.5 mIU/L (F31.60)) to prevent progression and functional morbidity.
Bipolar disorder, current episode mixed, moderate
Bipolar disorder, current episode mixed, moderate is an ICD-10-CM indexed diagnosis (F31.62) within Depression, Bipolar & Mood Disorders. Clinical evaluation centers on safety/support screening [Bipolar disorder, current episode mixed, moderate F31.62] alongside serial Serum Vitamin D in Bipolar disorder, current episode mixed, moderate (F31.62: & RBC Folate) tracking (25(OH)D 40 – 65 ng/mL (F31.62)) to guide individualized care.
Bipolar disorder, current episode mixed, severe, with psychotic features
Within Depression, Bipolar & Mood Disorders practice, Bipolar disorder, current episode mixed, severe, with psychotic features (ICD-10 F31.64) is stratified through medical mimic exclusion in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: (thyroid), pairing targeted symptom control with longitudinal TSH & Free in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: T4 Rule-Out) surveillance.
Bipolar disorder, currently in remission, most recent episode unspecified
For patients presenting with Bipolar disorder, currently in remission, most recent episode unspecified (ICD-10-CM F31.70), Depression, Bipolar & Mood Disorders protocols prioritize medical mimic exclusion in Bipolar disorder, currently in remission, most recent episode unspecified (F31.70: (thyroid) paired with baseline and interval TSH & Free in Bipolar disorder, currently in remission, most recent episode unspecified (F31.70: T4 Rule-Out) assessment.
Bipolar disorder, in full remission, most recent episode depressed
Designated in federal medical registries as F31.76, Bipolar disorder, in full remission, most recent episode depressed falls under Depression & Mood management, where validated longitudinal mood in Bipolar disorder, in full remission, most recent episode depressed (F31.76: rating scales (PHQ-9) establishes baseline severity and rules out diagnostic mimics.
Bipolar disorder, in full remission, most recent episode hypomanic
Clinical triage of Bipolar disorder, in full remission, most recent episode hypomanic (F31.72) in Depression & Mood relies on medication response pharmacogenomics [Bipolar disorder, in full remission, most recent episode hypomanic F31.72], guiding step-wise therapeutic adjustments toward Serum Vitamin D in Bipolar disorder, in full remission, most recent episode hypomanic (F31.72: & RBC Folate) (25(OH)D 40 – 65 ng/mL (F31.72)).
Bipolar disorder, in full remission, most recent episode manic
Bipolar disorder, in full remission, most recent episode manic—coded clinically as F31.74 across Depression & Mood guidelines—combines safety/support screening [Bipolar disorder, in full remission, most recent episode manic F31.74] with structured follow-up of TSH & Free in Bipolar disorder, in full remission, most recent episode manic (F31.74: T4 Rule-Out) (TSH 0.8 – 2.5 mIU/L (F31.74)).
Bipolar disorder, in partial remission, most recent episode hypomanic
Bipolar disorder, in partial remission, most recent episode hypomanic is an ICD-10-CM indexed diagnosis (F31.71) within Depression, Bipolar & Mood Disorders. Clinical evaluation centers on validated longitudinal mood in Bipolar disorder, in partial remission, most recent episode hypomanic (F31.71: rating scales (PHQ-9) alongside serial Serum Vitamin D in Bipolar disorder, in partial remission, most recent episode hypomanic (F31.71: & RBC Folate) tracking (25(OH)D 40 – 65 ng/mL (F31.71)) to guide individualized care.
Bipolar disorder, in partial remission, most recent episode manic
Physicians managing Bipolar disorder, in partial remission, most recent episode manic (F31.73; Depression, Bipolar & Mood Disorders) utilize sleep-wake rhythm assessment [Bipolar disorder, in partial remission, most recent episode manic F31.73] and objective Serum Vitamin D in Bipolar disorder, in partial remission, most recent episode manic (F31.73: & RBC Folate) targets (25(OH)D 40 – 65 ng/mL (F31.73)) to prevent progression and functional morbidity.
Bipolar disorder, in partial remission, most recent episode mixed
Physicians managing Bipolar disorder, in partial remission, most recent episode mixed (F31.77; Depression, Bipolar & Mood Disorders) utilize sleep-wake rhythm assessment [Bipolar disorder, in partial remission, most recent episode mixed F31.77] and objective PHQ-9 Symptom Severity in Bipolar disorder, in partial remission, most recent episode mixed (F31.77: Score) targets (< 4 (clinical remission) (F31.77)) to prevent progression and functional morbidity.
Depression
What is depression? Depression is more than a feeling of being sad or irritable for a few days. It's a serious mood disorder . As one of the most common mental disorders in the United States, depression can affect how you think, feel, and your everyday life. You may not know why you feel this way, but even basic daily activities such as sleeping, eating, or working may become difficult. Depression often needs long-term treatment but getting help at the earliest sign of a problem can help manage your symptoms. What are the different types of depression? The most common types of depression are major depression and persistent depressive disorder.
Disruptive mood dysregulation disorder
Cataloged under federal diagnostic code F34.81 in Depression & Mood, Disruptive mood dysregulation disorder requires validated longitudinal mood in Disruptive mood dysregulation disorder (F34.81: rating scales (PHQ-9) so specialists can calibrate treatment intensity against PHQ-9 Symptom Severity in Disruptive mood dysregulation disorder (F34.81: Score) benchmarks.
Drug abuse - IV
Within Depression, Bipolar & Mood Disorders practice, Drug abuse - IV (also termed Intravenous) (ICD-10 F19.10) is stratified through sleep-wake rhythm assessment [Drug abuse - IV F19.10], pairing targeted symptom control with longitudinal TSH & Free in Drug abuse - IV (F19.10: T4 Rule-Out) surveillance.
Drug abuse - mixed
Recognized across U.S. clinical coding as F19.10 (Depression & Mood), Drug abuse - mixed is evaluated via validated longitudinal mood in Drug abuse - mixed (F19.10: rating scales (PHQ-9) to align day-to-day symptom relief with long-term physiological stability.
Dysthymia
Dysthymia is an ICD-10-CM indexed diagnosis (F34.1) within Depression, Bipolar & Mood Disorders. Clinical evaluation centers on safety/support screening [Dysthymia F34.1] alongside serial Serum Vitamin D in Dysthymia (F34.1: & RBC Folate) tracking (25(OH)D 40 – 65 ng/mL (F34.1)) to guide individualized care.
Eclampsia - postpartum
Eclampsia - postpartum—coded clinically as O15.2 across Depression & Mood guidelines—combines validated longitudinal mood in Eclampsia - postpartum (O15.2: rating scales (PHQ-9) with structured follow-up of TSH & Free in Eclampsia - postpartum (O15.2: T4 Rule-Out) (TSH 0.8 – 2.5 mIU/L (O15.2)).
How to Improve Mental Health
What is mental health? Mental health includes our emotional, psychological, and social well-being. It affects how we think, feel, and act as we cope with life. It also helps determine how we handle stress , relate to others, and make choices. Mental health is important at every stage of life, from childhood and the teen years through adulthood and older age .
Hypochondriasis
Hypochondriasis is an ICD-10-CM indexed diagnosis (F45.21) within Depression, Bipolar & Mood Disorders. Clinical evaluation centers on validated longitudinal mood in Hypochondriasis (F45.21: rating scales (PHQ-9) alongside serial PHQ-9 Symptom Severity in Hypochondriasis (F45.21: Score) tracking (< 4 (clinical remission) (F45.21)) to guide individualized care.
Laxative abuse
Under Depression, Bipolar & Mood Disorders diagnostic criteria (F55.2), workup for Laxative abuse integrates medication response pharmacogenomics [Laxative abuse F55.2] with evidence-graded therapy tailored to TSH & Free in Laxative abuse (F55.2: T4 Rule-Out) response.
Leishmaniasis
Leishmaniasis is a parasitic disease spread by the bite of infected sand flies. There are several different forms of leishmaniasis. The most common are cutaneous and visceral. The cutaneous type causes skin sores. The visceral type affects internal organs such as the spleen, liver, and bone marrow. People with this form usually have fever, weight loss, and an enlarged spleen and liver. Leishmaniasis is found in parts of about 88 countries. Most of these countries are in the tropics and subtropics. It is possible but very unlikely that you would get this disease in the United States.
Major Depressive & Generalized Anxiety Disorders
Persistent affective anhedonia, autonomic hyperarousal, and cognitive executive slowing mediated by monoaminergic, HPA-axis, and neuroplastic circuit dysregulation.
Major depressive disorder, recurrent, in partial remission
Recognized across U.S. clinical coding as F33.41 (Depression & Mood), Major depressive disorder, recurrent, in partial remission is evaluated via sleep-wake rhythm assessment [Major depressive disorder, recurrent, in partial remission F33.41] to align day-to-day symptom relief with long-term physiological stability.
Major depressive disorder, recurrent, in remission
Clinical triage of Major depressive disorder, recurrent, in remission (F33.40) in Depression & Mood relies on medication response pharmacogenomics [Major depressive disorder, recurrent, in remission F33.40], guiding step-wise therapeutic adjustments toward PHQ-9 Symptom Severity in Major depressive disorder, recurrent, in remission (F33.40: Score) (< 4 (clinical remission) (F33.40)).
Major depressive disorder, recurrent, mild
Cataloged under federal diagnostic code F33.0 in Depression & Mood, Major depressive disorder, recurrent, mild requires medication response pharmacogenomics [Major depressive disorder, recurrent, mild F33.0] so specialists can calibrate treatment intensity against TSH & Free in Major depressive disorder, recurrent, mild (F33.0: T4 Rule-Out) benchmarks.
Major depressive disorder, recurrent, moderate
Physicians managing Major depressive disorder, recurrent, moderate (F33.1; Depression, Bipolar & Mood Disorders) utilize sleep-wake rhythm assessment [Major depressive disorder, recurrent, moderate F33.1] and objective PHQ-9 Symptom Severity in Major depressive disorder, recurrent, moderate (F33.1: Score) targets (< 4 (clinical remission) (F33.1)) to prevent progression and functional morbidity.
Major depressive disorder, recurrent, severe with psychotic symptoms
Under Depression, Bipolar & Mood Disorders diagnostic criteria (F33.3), workup for Major depressive disorder, recurrent, severe with psychotic symptoms integrates sleep-wake rhythm assessment [Major depressive disorder, recurrent, severe with psychotic symptoms F33.3] with evidence-graded therapy tailored to Serum Vitamin D in Major depressive disorder, recurrent, severe with psychotic symptoms (F33.3: & RBC Folate) response.
Major depressive disorder, single episode, in partial remission
Cataloged under federal diagnostic code F32.4 in Depression & Mood, Major depressive disorder, single episode, in partial remission requires safety/support screening [Major depressive disorder, single episode, in partial remission F32.4] so specialists can calibrate treatment intensity against Serum Vitamin D in Major depressive disorder, single episode, in partial remission (F32.4: & RBC Folate) benchmarks.
Major depressive disorder, single episode, mild
Major depressive disorder, single episode, mild is an ICD-10-CM indexed diagnosis (F32.0) within Depression, Bipolar & Mood Disorders. Clinical evaluation centers on structured psychiatric history [Major depressive disorder, single episode, mild F32.0] alongside serial Serum Vitamin D in Major depressive disorder, single episode, mild (F32.0: & RBC Folate) tracking (25(OH)D 40 – 65 ng/mL (F32.0)) to guide individualized care.
Major depressive disorder, single episode, moderate
Clinical triage of Major depressive disorder, single episode, moderate (F32.1) in Depression & Mood relies on medical mimic exclusion in Major depressive disorder, single episode, moderate (F32.1: (thyroid), guiding step-wise therapeutic adjustments toward Serum Vitamin D in Major depressive disorder, single episode, moderate (F32.1: & RBC Folate) (25(OH)D 40 – 65 ng/mL (F32.1)).
Major depressive disorder, single episode, severe with psychotic features
Physicians managing Major depressive disorder, single episode, severe with psychotic features (F32.3; Depression, Bipolar & Mood Disorders) utilize validated longitudinal mood in Major depressive disorder, single episode, severe with psychotic features (F32.3: rating scales (PHQ-9) and objective Serum Vitamin D in Major depressive disorder, single episode, severe with psychotic features (F32.3: & RBC Folate) targets (25(OH)D 40 – 65 ng/mL (F32.3)) to prevent progression and functional morbidity.
Manic episode
Cataloged under federal diagnostic code F30.9 in Depression & Mood, Manic episode requires medical mimic exclusion in Manic episode (F30.9: (thyroid) so specialists can calibrate treatment intensity against Serum Vitamin D in Manic episode (F30.9: & RBC Folate) benchmarks.
Manic episode in full remission
Clinical triage of Manic episode in full remission (F30.4) in Depression & Mood relies on medication response pharmacogenomics [Manic episode in full remission F30.4], guiding step-wise therapeutic adjustments toward Serum Vitamin D in Manic episode in full remission (F30.4: & RBC Folate) (25(OH)D 40 – 65 ng/mL (F30.4)).
Manic episode in partial remission
For patients presenting with Manic episode in partial remission (ICD-10-CM F30.3), Depression, Bipolar & Mood Disorders protocols prioritize medical mimic exclusion in Manic episode in partial remission (F30.3: (thyroid) paired with baseline and interval TSH & Free in Manic episode in partial remission (F30.3: T4 Rule-Out) assessment.
Manic episode without psychotic symptoms
For patients presenting with Manic episode without psychotic symptoms (ICD-10-CM F30.10), Depression, Bipolar & Mood Disorders protocols prioritize medication response pharmacogenomics [Manic episode without psychotic symptoms F30.10] paired with baseline and interval TSH & Free in Manic episode without psychotic symptoms (F30.10: T4 Rule-Out) assessment.
Manic episode without psychotic symptoms, mild
Recognized across U.S. clinical coding as F30.11 (Depression & Mood), Manic episode without psychotic symptoms, mild is evaluated via medication response pharmacogenomics [Manic episode without psychotic symptoms, mild F30.11] to align day-to-day symptom relief with long-term physiological stability.
Manic episode without psychotic symptoms, moderate
Designated in federal medical registries as F30.12, Manic episode without psychotic symptoms, moderate falls under Depression & Mood management, where safety/support screening [Manic episode without psychotic symptoms, moderate F30.12] establishes baseline severity and rules out diagnostic mimics.
Manic episode, severe with psychotic symptoms
Within Depression, Bipolar & Mood Disorders practice, Manic episode, severe with psychotic symptoms (ICD-10 F30.2) is stratified through safety/support screening [Manic episode, severe with psychotic symptoms F30.2], pairing targeted symptom control with longitudinal Serum Vitamin D in Manic episode, severe with psychotic symptoms (F30.2: & RBC Folate) surveillance.
Manic episode, severe, without psychotic symptoms
Within Depression, Bipolar & Mood Disorders practice, Manic episode, severe, without psychotic symptoms (ICD-10 F30.13) is stratified through sleep-wake rhythm assessment [Manic episode, severe, without psychotic symptoms F30.13], pairing targeted symptom control with longitudinal TSH & Free in Manic episode, severe, without psychotic symptoms (F30.13: T4 Rule-Out) surveillance.
Mood Disorders
Most people feel sad or irritable from time to time. They may say they're in a bad mood. A mood disorder is different. It affects a person's everyday emotional state. Nearly one in ten people aged 18 and older have mood disorders. These include depression and bipolar disorder (also called manic depression). Mood disorders can increase a person's risk for heart disease, diabetes, and other diseases. Treatments include medication, psychotherapy, or a combination of both. With treatment, most people with mood disorders can lead productive lives.
Mucocutaneous leishmaniasis
Under Depression, Bipolar & Mood Disorders diagnostic criteria (B55.2), workup for Mucocutaneous leishmaniasis integrates medical mimic exclusion in Mucocutaneous leishmaniasis (B55.2: (thyroid) with evidence-graded therapy tailored to TSH & Free in Mucocutaneous leishmaniasis (B55.2: T4 Rule-Out) response.
Neurosis
Under Depression, Bipolar & Mood Disorders diagnostic criteria (F48.9), workup for Neurosis integrates structured psychiatric history [Neurosis F48.9] with evidence-graded therapy tailored to Serum Vitamin D in Neurosis (F48.9: & RBC Folate) response.
Older Adult Mental Health
Mental health includes our emotional, psychological, and social well-being. It affects how we think, feel, and act as we cope with life. It also helps determine how we handle stress, relate to others, and make choices. Mental health is important at every stage of life, including as we age. Many older adults are at risk for mental health problems. But this does not mean that mental health problems are a normal part of aging. Studies show that most older adults feel satisfied with their lives, even though they may have more illnesses or physical problems. Sometimes, however, important life changes can make you feel uneasy, stressed, and sad.
Oppositional defiant disorder (ODD)
Clinical triage of Oppositional defiant disorder (ODD) (also termed Disorder or Syndrome) (F91.3) in Depression & Mood relies on medication response pharmacogenomics [Oppositional defiant disorder (ODD) F91.3], guiding step-wise therapeutic adjustments toward Serum Vitamin D in Oppositional defiant disorder (ODD) (F91.3: & RBC Folate) (25(OH)D 40 – 65 ng/mL (F91.3)).
Other bipolar disorder
Designated in federal medical registries as F31.89, Other bipolar disorder falls under Depression & Mood management, where sleep-wake rhythm assessment [Other bipolar disorder F31.89] establishes baseline severity and rules out diagnostic mimics.
Other manic episodes
Other manic episodes—coded clinically as F30.8 across Depression & Mood guidelines—combines medical mimic exclusion in Other manic episodes (F30.8: (thyroid) with structured follow-up of PHQ-9 Symptom Severity in Other manic episodes (F30.8: Score) (< 4 (clinical remission) (F30.8)).
Other recurrent depressive disorders
Cataloged under federal diagnostic code F33.8 in Depression & Mood, Other recurrent depressive disorders requires medication response pharmacogenomics [Other recurrent depressive disorders F33.8] so specialists can calibrate treatment intensity against TSH & Free in Other recurrent depressive disorders (F33.8: T4 Rule-Out) benchmarks.
Persistent mood [affective] disorder
Persistent mood [affective] disorder is an ICD-10-CM indexed diagnosis (F34.9) within Depression, Bipolar & Mood Disorders. Clinical evaluation centers on sleep-wake rhythm assessment [Persistent mood [affective] disorder F34.9] alongside serial Serum Vitamin D in Persistent mood [affective] disorder (F34.9: & RBC Folate) tracking (25(OH)D 40 – 65 ng/mL (F34.9)) to guide individualized care.
Personality disorder - paranoid
Personality disorder - paranoid (also termed Disorder or Syndrome)—coded clinically as F60.0 across Depression & Mood guidelines—combines medical mimic exclusion in Personality disorder - paranoid (F60.0: (thyroid) with structured follow-up of PHQ-9 Symptom Severity in Personality disorder - paranoid (F60.0: Score) (< 4 (clinical remission) (F60.0)).